008861 西部利得港股通新机遇混合A
价格图 ｜
基本资料 ｜
持仓明细 ｜
加入比较
| 代码 |
股票名称 |
占比 |
持股数（万股） |
持股市值（万元） |
截止日期 |
| 00013 |
和黄医药 |
7.75% |
15.55 |
383.13 |
2023-09-30 |
| 01801 |
信达生物 |
6.29% |
8.50 |
311.21 |
2023-09-30 |
| 01548 |
金斯瑞生物科技 |
6.13% |
15.80 |
303.02 |
2023-09-30 |
| 09995 |
荣昌生物 |
5.78% |
7.75 |
285.89 |
2023-09-30 |
| 06160 |
百济神州 |
4.83% |
2.32 |
239.08 |
2023-09-30 |
| 09926 |
康方生物 |
4.15% |
5.90 |
205.19 |
2023-09-30 |
| 02162 |
康诺亚-B |
4.13% |
4.05 |
204.40 |
2023-09-30 |
| 02273 |
固生堂 |
3.96% |
4.83 |
195.90 |
2023-09-30 |
| 03347 |
泰格医药 |
3.36% |
4.11 |
166.13 |
2023-09-30 |
| 00853 |
微创医疗 |
3.26% |
14.83 |
161.40 |
2023-09-30 |
资产配置
| 日期 |
股票占比 |
债券占比 |
现金占比 |
净资产（亿元） |
| 2023-09-30 |
90.29% |
4.08% |
4.48% |
0.49 |
| 2023-06-30 |
79.53% |
0.00% |
20.24% |
0.38 |
| 2023-03-31 |
83.67% |
0.00% |
21.91% |
0.42 |
| 2022-12-31 |
87.69% |
2.77% |
10.45% |
0.37 |
| 2022-09-30 |
74.85% |
0.00% |
25.60% |
0.34 |
| 2022-06-30 |
78.80% |
0.00% |
15.56% |
0.36 |
| 2022-03-31 |
77.31% |
0.00% |
24.03% |
0.37 |
| 2021-12-31 |
81.05% |
0.00% |
19.25% |
0.57 |
| 2021-09-30 |
84.14% |
0.00% |
16.43% |
0.64 |
| 2021-06-30 |
87.30% |
0.00% |
19.34% |
0.84 |
| 2021-03-31 |
91.65% |
0.00% |
13.53% |
0.84 |
| 2020-12-31 |
87.88% |
0.00% |
15.79% |
0.55 |
| 2020-09-30 |
86.87% |
0.00% |
13.45% |
0.54 |